Treatment Emergent Agranulocytosis with Skin and Gingival Lesions in a Chronic Lymphocytic Leukemia Patient: A Case Report

Treatment Emergent Agranulocytosis with Skin and Gingival Lesions in a Chronic Lymphocytic Leukemia Patient: A Case Report

Chronic Lymphocytic Leukaemia (CLL) is a monoclonal lymphoid malignancy characterized by progressive accumulation of small, mature but functionally incompetent neoplastic lymphocytes in the peripheral blood, bone marrow and lymphoid organs. Patients present a variable course and may not require ea...

Full description

Bibliographic Details
Main Authors:	Ramesh Amirisetty, Varun Zade, Meenakshi Boddun, Rolly Gupta, Micky Kumari, Hema Suryawanshi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2016-10-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	bendamustine gingival necrosis neutropenia rituximab
Online Access:	https://jcdr.net/articles/PDF/8662/21334_CE(Ra1)_F(AK)_PF1(T_NE)_PFA(AK)_PF2(EKAK).pdf

Similar Items

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01)

Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia
by: VV Strugov, et al.
Published: (2017-04-01)

Encephalopathy after Bendamustine Treatment: A Rare Side Effect?
by: Carolina Amado, et al.
Published: (2020-11-01)

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab
by: Tatsuro Jo, et al.
Published: (2014-07-01)

Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro
by: Ewelina Ziolkowska, et al.
Published: (2014-12-01)

Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia
by: YuV Mirolyubova, et al.
Published: (2018-04-01)

Minimal-change glomerulonephritis in chronic lymphocytic leukemia
by: B T Dzhumabaeva, et al.
Published: (2015-12-01)

Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
by: Martina Bogeljić Patekar, et al.
Published: (2018-01-01)

Chronic lymphocytic leukemia accompanied by renal failure
by: B T Dzhumabaeva, et al.
Published: (2014-12-01)

Painful, plantar nodules in cutaneous macroglobulinosis: Successful treatment with rituximab and bendamustine
by: Carmine D'Acunto, PhD, et al.
Published: (2020-10-01)

A case report of nodal marginal zone lymphoma: Diagnosis and management
by: Dilip Sandipan Nikam
Published: (2017-01-01)

Herpetic esophagitis following bendamustine-containing regimen
by: Yamane H, et al.
Published: (2016-06-01)

Bendamustine in the treatment of B-cell non-Hodgkin lymphoma
by: L G Babicheva, et al.
Published: (2018-12-01)

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study
by: Sara Galimberti, et al.
Published: (2017-06-01)

Ceftriaxone-induced Agranulocytosis
by: Lénio Couto, et al.
Published: (2021-01-01)

Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases)
by: B. T. Dzhumabaeva, et al.
Published: (2015-12-01)

Ongoing trials in low-grade lymphoma
by: Alexander Burchardt
Published: (2011-10-01)

Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: A serendipitous finding
by: B K Shah, et al.
Published: (2014-01-01)

Excellent response of rituximab and bendamustine in elderly patient with relapsed diffuse large B-cell lymphoma: a case report
by: Wiwiek Probowati, et al.
Published: (2021-01-01)

Efficacy of a bendamustine and rituximab combination in first-line therapy for chronic lymphocytic leukemia: Results of the BEN-001 study
by: E A Stadnik, et al.
Published: (2017-07-01)

Valproic Acid-induced Agranulocytosis
by: Hui-Chuan Hsu, et al.
Published: (2009-06-01)

Follicular lymphoma: first - line selection criteria of treatment
by: E S Nesterova, et al.
Published: (2019-08-01)

Neutropenia, agranulocytosis and dipyrone
by: Nelson Hamerschlak, et al.

Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Rituximab-induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease
by: Qasim Akram, et al.
Published: (2016-03-01)

New Approaches to Improving Bendamustine Microractor Synthesis
by: A. L. Moldavsky, et al.
Published: (2020-02-01)

Gingival Necrosis Caused by an Ill-Fitting Denture
by: Vanja VUČIĆEVIĆ BORAS, et al.
Published: (2014-01-01)

Late onset clozapine induced agranulocytosis
by: Rajmohan Velayudhan, et al.
Published: (2014-01-01)

Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia
by: Jessica Stokes, et al.
Published: (2020-01-01)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
by: Sara E. F. Kost, et al.
Published: (2019-10-01)

Oral Manifestations of T-Cell Large Granular Lymphocytic Leukemia: a Case Report
by: Ioanna-Eirini Arvanitidou, et al.
Published: (2011-06-01)

BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.
by: Roberto Castelli
Published: (2016-07-01)

AGRANULOCYTOSIS AND MACULOPAPULAR RASH AFTER TREATMENT WITH TICLOPIDINE – CASE REPORT
by: Janja Blatnik, et al.
Published: (2003-01-01)

Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis
by: Makoto Shibata, et al.
Published: (2021-06-01)

Experience with Evans syndrome in an academic referral center
by: José Carlos Jaime-Pérez, et al.
Published: (2015-08-01)

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility
by: James E, et al.
Published: (2021-03-01)

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
by: Antonio Cuneo, et al.
Published: (2020-11-01)

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01)

Cannot write session to /tmp/vufind_sessions/sess_0jbdjbdnlnuuq142go0613llpl